An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
NantHealth’s Chief Medical Officer to Educate on Advancing Equity in Cancer Care at the Oncology Clinical Pathways Congress 2021
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
NantHealth (NASDAQ: NH) announced that Dr. Tiffany Avery will present at the Oncology Clinical Pathways Congress 2021 on October 1, 2021. Her session, titled Utilizing Pathways to Advance Equity in Cancer Care, will focus on promoting equity in oncology and addressing biases in cancer treatment. Dr. Avery aims to highlight the importance of transparency in treatment options and the need for equitable patient care across diverse demographics.
Positive
Dr. Tiffany Avery's presentation enhances NantHealth's visibility in oncology.
Focus on equity in cancer care aligns with current healthcare trends.
Negative
None.
Dr. Tiffany Avery will discuss how the oncology community can promote care equity using pathways
EL SEGUNDO, Calif.--(BUSINESS WIRE)--
NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Dr. Tiffany Avery, Chief Medical Officer, was selected to present a continuing education session at the Oncology Clinical Pathways Congress 2021. Dr. Avery’s session, titled Utilizing Pathways to Advance Equity in Cancer Care, will take place virtually on Friday, October 1, 2021, and cover how clinical pathways can promote equity in oncology by recognizing the existence of bias in cancer care.
The Oncology Clinical Pathways Congress is a yearly meeting for those in the cancer care field to come together and positively impact the future of patient care. Dr. Avery will share the importance of recognizing bias in cancer care and acknowledging the disconnect that can lead to inequitable treatment. She will offer solutions to address disparities, provide transparency and affect change to ensure equitable treatment for all cancer patients regardless of their circumstances.
“The landscape of cancer care is rapidly evolving, and recognizing what stands in the way of equitable treatment is the first step in breaking down barriers that hinder patients from receiving the best care,” said Dr. Avery. “I look forward to the opportunity to share how the use of oncology pathways and adding health equity experts to guideline panels and advisory groups can provide transparency for stakeholders.”
Session Details
Title: “Utilizing Pathways to Advance Equity in Cancer Care”
Presenter: Dr. Tiffany Avery, Chief Medical Officer, NantHealth
Date and Time: Friday, October 1, 2021, 5:40-6:25 p.m. ET
NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. By offering efficient ways to move, interpret, and visualize complex and highly sensitive information, NantHealth enables customers in healthcare, life sciences, logistics, telecommunications and other industries to automate, understand and act on data while keeping it secure and scalable. NantHealth’s product portfolio comprises the latest technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet), and data solutions that provide multi-data analysis, reporting and professional services offerings (Quadris). The OpenNMS Group, Inc., a NantHealth subsidiary, helps businesses monitor and manage network health and performance. For more information, visit nanthealth.com, follow us on Twitter, Facebook, LinkedIn and YouTube, and subscribe to our blog.
Forward Looking Statement
This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Forward-looking statements can be identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. Risks and uncertainties include, but are not limited to: our ability to successfully integrate a complex learning system to address a wide range of healthcare issues; our ability to successfully amass the requisite data to achieve maximum network effects; appropriately allocating financial and human resources across a broad array of product and service offerings; raising additional capital as necessary to fund our operations; our ability to grow the market for our software and data solutions; successfully enhancing our software and data solutions to achieve market acceptance and keep pace with technological developments; customer concentration; competition; security breaches; bandwidth limitations; our ability to integrate The OpenNMS Group, Inc. into our operations; our use and distribution of open source software; our ability to obtain necessary regulatory approvals, certifications and licenses; dependence upon senior management; the need to comply with and meet applicable laws and regulations; unexpected adverse events; and anticipated cost savings. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our reports filed with the Securities and Exchange Commission.
